Novavax Covid Jab Highly Effective, But Not Against South Africa Variant

US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...

from NDTV News - Special https://ift.tt/36lyTbO

Comments

Popular posts from this blog

Viral Video Shows 3,000 Engineers Queuing Up For Job Interview In Pune

Asteroid Discovery Suggests Ingredients for Life on Earth Came From Space

Smith's Horrible DRS Call Has Kohli In Splits. 'Worst Review' Says Twitter